凯尼克萨制药 KNSA
$93.86 +$5.52 (+6.25%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $95.00 +1.21%
开盘$88.92
昨收$88.34
当日区间$88.41 – $94.48
成交量636.3K
市值$7.37B
市盈率（TTM）71.1
股息率–
KNSA 相关新闻
匹配 Kiniksa Pharmaceuticals International 或代码 KNSA 的头条新闻，按最新排序。
- Wells Fargo Initiates Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Announces Target Price $87
- CCORF Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Maintains Target Price $98
- A Quick Look at Today's Ratings for Kiniksa Pharmaceuticals International(KNSA.US), With a Forecast Between $87 to $107
- Goldman Sachs Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $90 正面
- Goldman Sachs Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $75 正面
- Wells Fargo Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $74 正面
- Wedbush Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $72 正面
- J.P. Morgan Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $72 正面
- A Quick Look at Today's Ratings for Kiniksa Pharmaceuticals International(KNSA.US), With a Forecast Between $57 to $71
- Wedbush Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $59 正面
- Wedbush Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $58 正面
- J.P. Morgan Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $68 正面
- Wells Fargo Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $53 正面
- CCORF Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Maintains Target Price $62
- Wedbush Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $53 正面
暂无评论——快来第一个聊聊 KNSA。
登录后参与讨论。